Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 NKTR-102 (PEG-Irinotecan) Demonstrates Significant Anti-Tumor Activity and Improved Pharmacokinetic Profile in Preclinical Studies Presented at ECCO Sep 27, 2007 Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting Sep 26, 2007 Nektar Therapeutics Creates New PEGylation and Pulmonary Research Units to Drive Innovative Technology-Based Product Pipeline Sep 18, 2007 Nektar Therapeutics President and CEO Howard Robin to Present at 2007 UBS Global Life Sciences Conference Sep 13, 2007 Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting Sep 10, 2007 Nektar Therapeutics Appoints Lutz Lingnau as New Board Member Aug 29, 2007 Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer Aug 23, 2007 Nektar Therapeutics Announces Second Quarter 2007 Financial Results Aug 08, 2007 Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias Aug 06, 2007 Anti-Tumor Activity and Pharmacokinetic Properties of NKTR-102 (PEG-irinotecan) to be Presented at Upcoming Oncology Meeting Jul 26, 2007 Pagination First page « first Previous page ‹ previous … Page 46 Page 47 Page 48 Page 49 Current page 50 Page 51 Page 52 Page 53 Page 54 … Next page next › Last page last »